ABSTRACT
We report a case of an advanced refractory Gastric AD which responded
favourably to a combination regimen of AGI and other chemotherapy
agents, which were selected on the basis of multi-analyte tumor
profiling. The treatment was well tolerated with transient manageable
adverse events and yielded radiological partial response.